Nitrosamine Contamination in Pharmaceuticals: A Retrospective Regulatory Analysis of USFDA Recalls and Risk Mitigation Strategies (2018–2025)
Crossref DOI link: https://doi.org/10.1007/s43441-025-00891-y
Published Online: 2025-11-17
Published Print: 2026-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yerram, Sravani
Muhammad Nizam, V. P.
Srivastava, Saurabh
Nanduri, Srinivas
Text and Data Mining valid from 2025-11-17
Version of Record valid from 2025-11-17
Article History
Received: 9 June 2025
Accepted: 13 October 2025
First Online: 17 November 2025
Declarations
:
: The authors declare no competing interests.